<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Protective effects of <z:chebi fb="0" ids="50114">estrogen</z:chebi> on nerve cells including <z:chebi fb="46" ids="15035">retinal</z:chebi> neurons have been described previously </plain></SENT>
<SENT sid="1" pm="."><plain>However, subcellular effects on synaptic connectivity in mild <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> more closely resembling ischemic conditions found in diabetic or sickle cell <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and stenosis of the carotid artery have not been identified </plain></SENT>
<SENT sid="2" pm="."><plain>The present study quantitatively analyzed effects of <z:chebi fb="0" ids="50114">estrogen</z:chebi> administration on synaptic connections of neurons in the ganglion cell layer (GCL) of the retina </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Staining of Vesl-1L/Homer 1c (V-1L) immunoreactivity and TUNEL cytochemistry were used to quantify neuroprotective effects at the synaptic level in a model of mild <z:mp ids='MP_0006190'>retinal ischemia</z:mp> induced by temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in the adult rat </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: V-1L immunoreactivity was found in both synaptic layers, postsynaptic to glutamatergic ribbon synapses </plain></SENT>
<SENT sid="5" pm="."><plain>Mild <z:mp ids='MP_0006190'>retinal ischemia</z:mp> led to a significantly higher percentage reduction in the number of V-1L-positive synapses in the inner plexiform layer (IPL) compared with the percentage of TUNEL-positive apoptotic neurons in the GCL </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> prevented <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced loss of V-1L-immunoreactive synapses in the IPL and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of cells in the GCL </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Immunoreactivity for V-1L can be used as a synaptic marker for early changes before more severe neurodegenerative events </plain></SENT>
<SENT sid="8" pm="."><plain>The present results suggest that <z:chebi fb="0" ids="50114">estrogen</z:chebi> protects neurons in the GCL including RGCs from both <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and early changes in synaptic connections associated with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and potentially preceding <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>